Nifty
Sensex
:
:
15789.90
52551.77
-79.35 (-0.50%)
-221.28 (-0.42%)

Pharmaceuticals & Drugs - API

Rating :
46/99

BSE: 506235 | NSE: ALEMBICLTD

130.05
15-Jun-2021
  • Open
  • High
  • Low
  • Previous Close
  •  130.20
  •  131.95
  •  129.55
  •  129.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  373621
  •  486.95
  •  143.30
  •  73.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,338.16
  • 9.74
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,279.31
  • 0.46%
  • 1.80

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.73%
  • 19.84%
  • FII
  • DII
  • Others
  • 1.6%
  • 4.29%
  • 2.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.59
  • -10.33
  • -16.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.78
  • -9.46
  • -19.92

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 30.35
  • 30.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.73
  • 6.58
  • 6.51

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.44
  • 1.27
  • 1.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.95
  • 30.99
  • 30.52

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
28.89
11.48
151.66%
14.48
12.76
13.48%
16.76
23.65
-29.13%
13.39
26.03
-48.56%
Expenses
24.95
12.14
105.52%
10.58
12.88
-17.86%
14.28
20.99
-31.97%
12.65
24.62
-48.62%
EBITDA
3.94
-0.66
-
3.90
-0.12
-
2.48
2.66
-6.77%
0.74
1.41
-47.52%
EBIDTM
13.64%
-5.75%
26.93%
-0.94%
14.74%
11.25%
5.53%
5.42%
Other Income
1.77
57.28
-96.91%
3.02
2.06
46.60%
2.68
32.58
-91.77%
2.82
1.48
90.54%
Interest
0.09
0.09
0.00%
0.10
0.07
42.86%
0.08
0.06
33.33%
0.09
0.07
28.57%
Depreciation
1.03
0.90
14.44%
1.02
0.93
9.68%
0.97
0.71
36.62%
0.93
0.69
34.78%
PBT
4.59
55.63
-91.75%
5.80
0.94
517.02%
4.10
34.47
-88.11%
2.54
2.13
19.25%
Tax
0.95
0.16
493.75%
0.93
0.01
9,200.00%
0.89
-0.68
-
0.43
0.64
-32.81%
PAT
3.64
55.47
-93.44%
4.87
0.93
423.66%
3.21
35.15
-90.87%
2.11
1.49
41.61%
PATM
12.60%
483.19%
33.63%
7.29%
19.15%
148.63%
15.76%
5.72%
EPS
2.80
4.50
-37.78%
3.33
2.65
25.66%
3.77
4.24
-11.08%
3.45
1.43
141.26%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Net Sales
73.52
73.93
123.81
125.30
147.16
127.53
143.95
1,138.14
1,116.07
994.44
Net Sales Growth
-0.54%
-40.29%
-1.19%
-14.85%
15.39%
-11.41%
-87.35%
1.98%
12.23%
 
Cost Of Goods Sold
9.38
12.17
54.07
78.50
96.33
69.67
74.09
572.04
559.08
484.02
Gross Profit
64.14
61.75
69.74
46.79
50.83
57.86
69.86
566.10
556.99
510.43
GP Margin
87.24%
83.52%
56.33%
37.34%
34.54%
45.37%
48.53%
49.74%
49.91%
51.33%
Total Expenditure
62.46
70.28
105.74
114.22
140.45
121.53
135.35
1,024.55
1,031.58
848.36
Power & Fuel Cost
-
0.91
2.34
1.11
5.46
13.26
13.30
33.98
38.08
28.05
% Of Sales
-
1.23%
1.89%
0.89%
3.71%
10.40%
9.24%
2.99%
3.41%
2.82%
Employee Cost
-
20.79
20.52
19.64
22.83
23.79
27.00
145.47
131.69
97.62
% Of Sales
-
28.12%
16.57%
15.67%
15.51%
18.65%
18.76%
12.78%
11.80%
9.82%
Manufacturing Exp.
-
25.52
20.00
6.08
7.11
5.77
11.90
91.62
96.22
90.89
% Of Sales
-
34.52%
16.15%
4.85%
4.83%
4.52%
8.27%
8.05%
8.62%
9.14%
General & Admin Exp.
-
8.30
7.15
6.80
6.48
5.30
4.66
76.82
68.22
53.45
% Of Sales
-
11.23%
5.77%
5.43%
4.40%
4.16%
3.24%
6.75%
6.11%
5.37%
Selling & Distn. Exp.
-
0.87
0.11
0.34
0.90
2.11
2.88
92.16
87.12
79.71
% Of Sales
-
1.18%
0.09%
0.27%
0.61%
1.65%
2.00%
8.10%
7.81%
8.02%
Miscellaneous Exp.
-
1.72
1.56
1.75
1.33
1.64
1.51
12.45
51.18
14.63
% Of Sales
-
2.33%
1.26%
1.40%
0.90%
1.29%
1.05%
1.09%
4.59%
1.47%
EBITDA
11.06
3.65
18.07
11.08
6.71
6.00
8.60
113.59
84.49
146.08
EBITDA Margin
15.04%
4.94%
14.59%
8.84%
4.56%
4.70%
5.97%
9.98%
7.57%
14.69%
Other Income
10.29
93.04
29.45
37.04
30.97
28.81
21.73
11.22
15.01
34.85
Interest
0.36
0.29
0.22
0.17
0.16
0.12
0.83
37.98
52.06
34.56
Depreciation
3.95
3.23
2.63
3.78
5.09
6.14
6.04
43.02
38.31
32.77
PBT
17.03
93.17
44.67
44.18
32.44
28.55
23.46
43.81
9.13
113.60
Tax
3.20
0.13
3.59
2.39
-0.86
0.61
-0.69
4.27
-1.69
1.95
Tax Rate
18.79%
0.14%
8.04%
5.41%
-3.23%
2.41%
-2.94%
9.75%
-18.51%
1.72%
PAT
13.83
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
111.65
PAT before Minority Interest
13.83
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
111.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.81%
125.84%
33.18%
33.34%
18.68%
19.38%
16.78%
3.47%
0.97%
11.23%
PAT Growth
-85.14%
126.46%
-1.68%
51.98%
11.21%
2.36%
-38.92%
265.43%
-90.31%
 
EPS
0.54
3.62
1.60
1.63
1.07
0.96
0.94
1.54
0.42
4.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,418.04
1,208.53
1,085.77
911.43
803.13
527.81
337.29
331.01
341.37
Share Capital
51.36
51.36
53.41
53.41
53.41
53.41
26.70
27.44
27.69
Total Reserves
1,366.69
1,157.17
1,032.37
858.02
749.72
474.40
310.58
303.57
313.67
Non-Current Liabilities
6.88
8.52
14.15
12.61
14.69
38.03
422.22
481.85
418.64
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
249.31
215.76
277.55
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
159.06
259.68
145.92
Long Term Provisions
0.70
0.72
0.80
0.78
0.64
1.57
0.00
0.00
0.00
Current Liabilities
45.80
48.80
59.12
68.34
57.68
81.80
269.87
230.03
203.88
Trade Payables
12.99
24.75
16.42
14.76
16.36
19.19
197.79
169.19
136.88
Other Current Liabilities
22.07
8.07
31.82
39.20
27.37
26.22
20.42
18.97
15.31
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
10.74
15.97
10.89
14.38
13.95
36.39
51.66
41.87
51.69
Total Liabilities
1,470.72
1,265.85
1,159.04
992.38
875.50
647.64
1,029.38
1,042.89
963.89
Net Block
209.47
186.88
147.46
147.60
146.42
169.02
393.18
404.78
366.62
Gross Block
228.24
202.45
160.37
158.33
371.75
402.34
712.34
681.78
605.50
Accumulated Depreciation
18.78
15.57
12.92
10.73
225.34
233.33
319.15
277.00
238.88
Non Current Assets
1,307.90
1,167.08
972.32
801.10
706.29
458.23
405.46
420.29
401.28
Capital Work in Progress
18.69
22.26
31.64
0.16
0.00
2.47
3.90
7.16
21.96
Non Current Investment
1,078.88
957.76
792.85
651.28
558.62
286.52
8.37
8.33
12.70
Long Term Loans & Adv.
0.86
0.17
0.38
2.05
1.25
0.23
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
162.82
98.77
186.73
191.28
169.21
189.41
623.91
622.60
562.61
Current Investments
53.71
43.46
119.85
104.76
46.13
12.23
0.00
0.00
1.35
Inventories
35.41
35.33
32.41
50.61
74.90
84.31
244.95
238.39
202.81
Sundry Debtors
8.98
13.51
25.29
21.60
27.98
48.04
192.87
213.00
230.54
Cash & Bank
58.85
2.01
0.84
2.32
2.34
2.64
23.85
16.41
18.66
Other Current Assets
5.86
1.88
2.01
2.10
17.87
42.19
162.25
154.81
109.24
Short Term Loans & Adv.
4.38
2.59
6.34
9.88
16.24
42.19
162.25
154.81
109.24
Net Current Assets
117.03
49.97
127.61
122.94
111.53
107.61
354.04
392.57
358.73
Total Assets
1,470.72
1,265.85
1,159.05
992.38
875.50
647.64
1,029.37
1,042.89
963.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
6.17
21.51
23.58
51.63
9.65
149.09
123.09
53.54
PBT
93.17
44.67
44.18
26.63
25.33
43.81
16.65
91.05
Adjustment
-85.70
-20.51
-28.85
-20.86
-16.51
73.14
113.95
59.65
Changes in Working Capital
0.24
1.99
11.89
46.06
1.70
36.16
-4.37
-109.70
Cash after chg. in Working capital
7.70
26.15
27.22
51.83
10.52
153.11
126.23
41.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.53
-4.64
-3.64
-0.20
-0.87
-4.02
-3.13
-3.27
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-6.75
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
56.72
71.67
-22.40
-46.69
-4.76
-23.50
-55.55
-225.13
Net Fixed Assets
-22.22
-32.70
-33.47
213.26
344.49
-27.30
-61.48
Net Investments
7.99
70.53
-63.48
-62.37
-141.47
-0.04
5.60
Others
70.95
33.84
74.55
-197.58
-207.78
3.84
0.33
Cash from Financing Activity
-6.05
-92.01
-2.66
-4.96
-5.19
-118.15
-69.79
38.55
Net Cash Inflow / Outflow
56.85
1.17
-1.48
-0.02
-0.30
7.45
-2.25
-133.05
Opening Cash & Equivalents
2.01
0.84
2.32
2.34
2.64
16.41
18.66
151.71
Closing Cash & Equivalent
58.85
2.01
0.84
2.32
2.34
23.85
16.41
18.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
55.22
47.06
40.66
34.13
30.08
19.77
12.63
12.06
12.33
ROA
6.80%
3.39%
3.88%
2.94%
3.25%
2.88%
3.82%
1.08%
11.58%
ROE
7.08%
3.58%
4.18%
3.21%
3.71%
5.58%
11.83%
3.22%
32.71%
ROCE
7.12%
3.91%
4.44%
3.12%
3.82%
3.82%
10.54%
7.79%
19.37%
Fixed Asset Turnover
0.34
0.68
0.80
0.58
0.35
0.27
1.65
1.76
1.70
Receivable days
55.52
57.19
67.34
59.14
103.47
293.96
64.48
71.40
81.97
Inventory Days
174.64
99.84
119.22
149.70
216.71
401.78
76.79
71.03
72.11
Payable days
120.48
74.61
55.73
40.49
60.75
331.66
68.63
56.58
59.67
Cash Conversion Cycle
109.68
82.42
130.83
168.35
259.43
364.08
72.65
85.84
94.40
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
1.21
1.44
1.24
Interest Cover
324.49
207.64
261.78
169.23
221.26
29.30
2.15
1.18
4.29

Top Investors:

News Update:


  • Alembic reports 38% fall in Q4 consolidated net profit
    12th May 2021, 12:12 PM

    Total consolidated income of the company decreased by 55.41% at Rs 30.66 crore for Q4FY21

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.